AMPIO PHARMACEUTICALS, INC. : Entering into a Material Definitive Agreement, Change of Directors or Principal Officers, Financial Statements and Exhibits (Form 8-K)
Item 1.01. Conclusion of a significant definitive agreement.
Research Services Agreement
As part of the research services agreement, the Company and
personal services contract
for his services as Principal Investigator, payable in equal quarterly installments. This replaces boarding fees
The foregoing descriptions of the Research Services Agreement and the Personal Services Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of those agreements, copies of which will be filed as exhibits to the quarterly company report on Form 10-Q for the period ended
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Section 5.02. Departure of directors or certain managers; Election of directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
and treatment options for diseases such as psoriasis, lupus and multiple sclerosis. Prior to
There are no arrangements or agreements between
For his service to the Board of Directors and the NCGC,
Additional details regarding the foregoing can be found in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K, which is hereby incorporated by reference.
Item 9.01 Financial statements and supporting documents.
(d) Exhibits. 99.1 Press release, dated
February 10, 2022104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
© Edgar Online, source